| Literature DB >> 28944836 |
Sheng-Chao Ma1, Jian-Cheng Cao1, Hui-Ping Zhang2, Yun Jiao3, Hui Zhang1, Yang-Yang He1, Yan-Hua Wang1, Xiao-Ling Yang1, An-Ning Yang1, Jue Tian1, Ming-Hao Zhang1, Xiao-Ming Yang1, Guan-Jun Lu4, Shao-Ju Jin1, Yue-Xia Jia1, Yi-Deng Jiang1.
Abstract
Vascular smooth muscle cell (VSMC) proliferation is a primary pathological event in atherosclerosis (AS), and homocysteine (Hcy) is an independent risk factor for AS. However, the underlying mechanisms are still lagging. Studies have used the combination of methylation of promoters of multiple genes to diagnose tumors, thus the aim of the current study was to investigate the role of methylation status of several genes in VSMCs treated with Hcy. CpG islands were identified in the promoters of platelet‑derived growth factor (PDGF), p53, phosphatase and tensin homologue on chromosome 10 (PTEN) and mitofusin 2 (MFN2). Hypomethylation was observed to occur in the promoter region of PDGF, hypermethylation in p53, PTEN and MFN2, and hypomethylation in two global methylation indicators, aluminium (Alu) and long interspersed nucleotide element‑1 (Line‑1). This was accompanied by an increase in the expression of PDGF, and reductions of p53, PTEN and MFN2, both in mRNA and protein levels. An elevation of S‑adenosylmethionine (SAM) and a reduction of S‑adenosylhomocysteine (SAH) and the SAM/SAH ratio were also identified. In conclusion, Hcy impacted methylation the of AS‑associated genes and global methylation status that mediate the cell proliferation, which may be a character of VSMCs treated with Hcy. The data provided evidence for mechanisms of VSMCs proliferation in AS induced by Hcy and may provide a new perspective for AS induced by Hcy.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28944836 DOI: 10.3892/mmr.2017.7521
Source DB: PubMed Journal: Mol Med Rep ISSN: 1791-2997 Impact factor: 2.952